Biocon Pledges To Cut Insulin Prices
India’s Biocon has pledged to cut the price of insulin to 10 cents per day in low- and middle-income nations
India’s Biocon has promised to cut by 50% the cost of recombinant human insulin to 10 cents a day in low- and middle-income nations to help make the life-saving medication “universally accessible.”
